dr. bunn on tmb as a biomarker in small cell lung cancer
Published 5 years ago • 159 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
1:42
dr. herbst on tmb as a biomarker in nsclc
-
2:43
dr. bunn on immunotherapy advances in small cell lung cancer
-
3:18
tmb as a predictive biomarker in nsclc
-
7:29
blood-based tmb as a predictive biomarker in nsclc
-
1:31
dr. bunn on combining immunotherapy and chemotherapy in lung cancer
-
1:39
dr. bunn on the mystic trial for lung cancer
-
4:12
tumor mutation burden as a biomarker in nsclc
-
6:55
tmb and immunotherapy in advanced nsclc
-
1:25
dr. bunn discusses afatinib in lung cancer
-
1:14
dr. bunn on current role of precision medicine for lung cancer
-
2:06
dr. bunn on initial results of the mystic trial in stage iv lung cancer
-
1:29
dr. bunn on the response of immunotherapy in lung cancer
-
3:22
dr. bunn discusses the need to study drug combinations in lung cancer
-
3:43
biomarkers in nsclc: a pathologist's insight into pd-l1 and tmb
-
5:51
checkmate-227 and the role of tmb in nsclc
-
8:02
role of tumor mutational burden in nsclc
-
1:36
dr. bunn discusses companion diagnostic tests in lung cancer
-
4:51
tumor mutational burden in nsclc: should it be routine?
-
1:08
sai-hong ignatius ou, md, phd, comments on tumor mutation burden (tmb) as a biomarker in nsclc